On 2 July 2012, GlaxoSmithKline pleaded guilty to criminal charges and agreed to a $3 billion settlement of the largest health-care fraud case in the U.S. and the largest payment by a drug company. The settlement is related to the company's illegal promotion of prescription drugs, its failure to report safety data, bribing doctors, and promoting medicines for uses for which they were not licensed. The drugs involved were Paxil, Wellbutrin, Advair, Lamictal, and Zofran for off-label, non-covered uses. Those and the drugs Imitrex, Lotronex, Flovent, and Valtrex were involved in the kickback scheme. COUNT 8
QSN1 How much was the settlement GlaxoSmithKline agree to? ANS1 $3 billion QSN2 What was one of the causes of the health-care fraud case? ANS2 illegal promotion of prescription drugs QSN3 When did GlaxoSmithKline plead guilty? ANS3 2 July 2012 QSN4 What drugs were related to a kickback scheme? ANS4 Imitrex, Lotronex, Flovent, and Valtrex QSN5 What drugs were used for off-label uses? ANS5 Paxil, Wellbutrin, Advair, Lamictal, and Zofran QSN6 In what year did GlaxoSmithKline pay a $3 billion dollar settlement? ANS6 2012 QSN7 How much was the largest healthcare fraud case in the US settled for? ANS7 $3 billion QSN8 What company was sued for promoting medicines for unlicensed uses and bribing doctors? ANS8 GlaxoSmithKline